Page last updated: 2024-08-24

zanamivir and Neoplasms

zanamivir has been researched along with Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Angeles-Garay, U; Arias-Flores, R; Gayosso Rivera, JA; Rechy-Luna, M; Terrazas Estrada, JJ; Zacate-Palacios, Y	1
Henney, JE	1

Other Studies

2 other study(ies) available for zanamivir and Neoplasms

Article	Year
[Clinical features and contagiousness of influenza A(H1N1) in health care workers and hospitalized patients in a Mexico City hospital]. Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29, Issue:9 Topics: Adult; Aged; Antiviral Agents; Comorbidity; Contact Tracing; Cross Infection; Disease Outbreaks; Female; Hospital Mortality; Hospitals, Urban; Humans; Immunocompromised Host; Infectious Disease Transmission, Patient-to-Professional; Infectious Disease Transmission, Professional-to-Patient; Influenza A Virus, H1N1 Subtype; Influenza, Human; Inpatients; Male; Mexico; Middle Aged; Neoplasms; Occupational Diseases; Oseltamivir; Personnel, Hospital; Virulence; Zanamivir	2011
From the Food and Drug Administration. JAMA, 2000, Sep-13, Volume: 284, Issue:10 Topics: Administration, Oral; Antiviral Agents; Cyclosporine; Drug and Narcotic Control; Drug Labeling; Fluoxetine; Guanidines; Health Education; Humans; Immunosuppressive Agents; Internet; Neoplasms; Premenstrual Syndrome; Pyrans; Selective Serotonin Reuptake Inhibitors; Sialic Acids; United States; United States Food and Drug Administration; Zanamivir	2000

Article

Year

[Clinical features and contagiousness of influenza A(H1N1) in health care workers and hospitalized patients in a Mexico City hospital].

Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29, Issue:9

Topics: Adult; Aged; Antiviral Agents; Comorbidity; Contact Tracing; Cross Infection; Disease Outbreaks; Female; Hospital Mortality; Hospitals, Urban; Humans; Immunocompromised Host; Infectious Disease Transmission, Patient-to-Professional; Infectious Disease Transmission, Professional-to-Patient; Influenza A Virus, H1N1 Subtype; Influenza, Human; Inpatients; Male; Mexico; Middle Aged; Neoplasms; Occupational Diseases; Oseltamivir; Personnel, Hospital; Virulence; Zanamivir

2011

From the Food and Drug Administration.

JAMA, 2000, Sep-13, Volume: 284, Issue:10

Topics: Administration, Oral; Antiviral Agents; Cyclosporine; Drug and Narcotic Control; Drug Labeling; Fluoxetine; Guanidines; Health Education; Humans; Immunosuppressive Agents; Internet; Neoplasms; Premenstrual Syndrome; Pyrans; Selective Serotonin Reuptake Inhibitors; Sialic Acids; United States; United States Food and Drug Administration; Zanamivir

2000